248 related articles for article (PubMed ID: 25537234)
1. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.
Lopez-Gonzalez E; Herdeiro MT; Piñeiro-Lamas M; Figueiras A;
Drug Saf; 2015 Feb; 38(2):189-96. PubMed ID: 25537234
[TBL] [Abstract][Full Text] [Related]
2. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
[TBL] [Abstract][Full Text] [Related]
3. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A
Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
6. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.
Herdeiro MT; Polónia J; Gestal-Otero JJ; Figueiras A
Drug Saf; 2008; 31(4):335-44. PubMed ID: 18366244
[TBL] [Abstract][Full Text] [Related]
7. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.
Pedrós C; Vallano A; Cereza G; Mendoza-Aran G; Agustí A; Aguilera C; Danés I; Vidal X; Arnau JM
Drug Saf; 2009; 32(1):77-83. PubMed ID: 19132807
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China.
Fang H; Lin X; Zhang J; Hong Z; Sugiyama K; Nozaki T; Sameshima T; Kobayashi S; Namba H; Asakawa T
BMC Pharmacol Toxicol; 2017 Jun; 18(1):49. PubMed ID: 28651624
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.
Nadew SS; Beyene KG; Beza SW
PLoS One; 2020; 15(1):e0227712. PubMed ID: 31961883
[TBL] [Abstract][Full Text] [Related]
10. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
Johansson ML; Hägg S; Wallerstedt SM
BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
[TBL] [Abstract][Full Text] [Related]
11. Detection of adverse drug reactions through the minimum basic data set.
Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
[TBL] [Abstract][Full Text] [Related]
12. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
13. A time series analysis of the effects of financial incentives and mandatory clinical applications as interventions to improve spontaneous adverse drug reaction reporting by hospital medical staff in China.
Chang F; Xi Y; Zhao J; Zhang X; Lu Y
J Eval Clin Pract; 2017 Dec; 23(6):1316-1321. PubMed ID: 28675578
[TBL] [Abstract][Full Text] [Related]
14. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
15. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
16. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
[TBL] [Abstract][Full Text] [Related]
17. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.
Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R
Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615
[TBL] [Abstract][Full Text] [Related]
18. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
[TBL] [Abstract][Full Text] [Related]
19. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.
Sanghavi DR; Dhande PP; Pandit VA
Int J Risk Saf Med; 2013; 25(4):197-204. PubMed ID: 24305558
[TBL] [Abstract][Full Text] [Related]
20. Improving the data quality of spontaneous ADR reports: a practical example from Malta.
Zuccarelli M; Micallef B; Butler D; Serracino-Inglott A; Borg JJ
Expert Opin Drug Saf; 2022 Feb; 21(2):253-268. PubMed ID: 34649475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
